SB0167: PFAS-CHILD PRODUCTS
Legislative Summary
Amends the PFAS Reduction Act. Provides that, beginning January 1, 2026, a person may not sell, offer for sale, or distribute for sale in this State a juvenile product if the product or a product component contains intentionally added PFAS. Provides for enforcement. Exempts from the Act's requirements products that are federally preempted, products already regulated by the Act, used products, prosthetic or orthotic devices, and any medical device or drug used in a medical setting or in medical applications regulated by the United States Food and Drug Administration. Defines terms.
Demographic Impact
Overall analysis of equity impact
Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
